心脏支架介入与溶栓血运重建再灌注在ST段抬高急性心肌梗死患者中的应用

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application of cardiac stenting and thrombolysis and reperfusion in patients with ST-segment elevation acute myocardial infarction (STEMI).Methods Forty-six patients with STEMI admitted to our hospital from December 2016 to October 2018 were enrolled in the study.They were divided into control group (n=23) and observed group (n=23) according to the random number table method.The patients in the control group were treated with cardiac stenting.The patients in the observation group were treated with thrombolysis and reperfusion.The serum myocardial necrosis markers, inflammatory factors and left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter (LVEDD) and primary endpoint (mortality, rate of re-infarction) were observed in the two groups.Results Creatine kinase isoenzyme(CK-MB),cardiac troponin I(cTnI), serum high-sensitivity C-reactive protein(hs-CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10) were lower than those of the control group, the differences were statistically significant (P<0.05).The LVEF of the observation group was higher than that of the control group and LVEDD was lower than the control group, the difference was statistically significant(P<0.05).The mortality and re-infarction rate of the observation group were lower than those of the control group, and the differences were statistically significant (P<0.05).Conclusion The effect of thrombolysis and reperfusion treating STEMI is more significant,and it can effectively improve the relevant indicators of patients.It is more advantageous than cardiac stenting and is suitable for clinical development and implementation.

Key words： ST-segment elevation acute myocardial infarction Cardiac stent intervention Thrombolysis and reperfusion Therapeutic effect Comparison

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHENG Qian-kun

Cite this article:

CHENG Qian-kun. Application of cardiac stenting and thrombolysis and reperfusion in patients with ST-segment elevation acute myocardial infarction[J]. 中国当代医药, 2020, 27(12): 67-69.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I12/67

[1]	李严，李晓雯，张迎花，等.血糖控制状态对急性ST段抬高型心肌梗死行经皮冠状动脉介入治疗的糖尿病患者预后的影响[J].中国心血管杂志，2019，24（4）：319-323.
[2]	吴彩凤，徐日新，张强，等.微循环阻力指数评估急性前壁ST段抬高型心肌梗死患者急诊冠状动脉介入治疗预后的价值及相关影响因素[J].实用临床医药杂志，2019，23（16）：65-69，75.
[3]	陈要起，穆金兴，陈洪波，等.冠状动脉内应用比伐卢定对急性非ST段抬高型心肌梗死高危患者早期PCI 术预后的影响[J].疑难病杂志，2019，18（8）：765-769，774.
[4]	Huded CP，Johnson M，Kravitz K，et al.Four-step protocol for disparities in STEMI care and outcomes in women[J].J Am Coll Cardiol，2018，71（19）：S0735109718333709.
[5]	沈印，朱良峰，吕立文，等.急性ST段抬高型心肌梗死患者的临床特征及接受急诊经皮冠状动脉介入治疗的影响因素[J].广西医学，2019，41（15）：1941-1945.
[6]	Rhyou HI，Park TH，Cho YR，et al.Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI[J].J Cardiol，2018，71（2）：S0914508717302368.
[7]	周国亮，王艳茹，张月婵，等.急性ST段抬高型心肌梗死患者PCI 术应用替格瑞洛对心功能变化及不良心脑血管事件发生的影响[J].解放军医药杂志，2019，31（8）：86-89.
[8]	茹燕，阎晓宇.三维斑点追踪成像技术在ST段抬高型急性心肌梗死患者经皮冠状动脉介入术后左心室收缩功能评估中的应用[J].实用医学影像杂志，2019，20（4）：405-406.
[9]	颜红兵，向定成，刘红梅，等.ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识[J].中国介入心脏病学杂志，2018，26（4）：181-190.
[10]	李龙，谢翔.ST段抬高型急性心肌梗死合并多支血管病变经皮冠状动脉介入治疗方案选择研究进展[J].中华实用诊断与治疗杂志，2018，32（4）：395-398.
[11]	翟光耀，高霏，王建龙，等.ST段抬高型急性心肌梗死直接经皮冠状动脉介入治疗是否同期处理的对比研究[J].心肺血管病杂志，2018，37（7）：597-600.
[12]	周秀金.干燥综合征误诊为急性非ST段抬高型心肌梗死一例[J].中国医师杂志，2018，20（1）：146-147.
[13]	隆海文，谢迎春，甘剑挺.老年ST段抬高型急性心肌梗死转运PCI 应用替罗非班的临床观察[J].心脑血管病防治，2018，18（1）：54-56.
[14]	徐航，冯小梅.ST段抬高型急性心肌梗死合并J 波综合征患者的心电图特征[J].心血管康复医学杂志，2018，27（2）：97-100.
[15]	周梦灵.65例非ST段抬高型急性心肌梗死患者临床特征及预后分析[J].河南医学研究，2018，27（6）：109-110.
[16]	晁银霞，王勇，牛文堂，等.药物支架介入治疗后心脏事件发生情况及危险因素研究[J].中国医师杂志，2017，19（2）：284-287.
[17]	许丽霞，张丽科，杨云山，等.微小RNA-499 对STEMI 的早期诊断价值[J].检验医学与临床，2017，14（21）：3191-3192.